TCTR20190722005招募中3 期
The efficacy and safety of 0.5% topical timolol on corneometry and transepidermal water loss after ablative fractional CO2 laser for atrophic acne scars: a split face randomized double blind placebo-controlled trial
none0 个研究点目标入组 25 人开始时间: 2019年7月22日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 50 Years（—）
- 性别
- All
入选标准
- •The participants aged 18-50 years old with atrophic area scars for at least three months
排除标准
- •1) pregnant/lactating female, 2) history of isotretinoin use within previous 3 months before enrollment, 3) history of cosmetic procedures including botulinum toxin, filler, collagen, lasers within the preceding 3 months, 4) history of photosensitivity or skin cancer, 5) history of psoriasis, hypertension, or asthma, 6) allergy to anesthetic agents, or timolol solution, 7) active dermatitis or herpes infection (within previous 2 weeks), 8) Fitzpatrick skin type V †VI, 9) current or history of previous use within one month of anticoagulative drugs or NSAIDs use or previous use
研究者
相似试验
尚未招募
4 期
sefulness of Timolol in a condition of vascular overgrowth of tissueCTRI/2019/04/018581Indian Association of Dermatologists Venereologists and Leprologists Research grant
已完成
不适用
Evaluation of a new substance (isobutylamido thiazolyl resorcinolcream) compared to the use of hydroquinone 4% cream to treat facial blemishesMelasmaRBR-87kphyFaculdade de Medicina de Botucatu (FMB - Unesp)
招募中
2 期
Evaluation of efficacy of Topical Timolol for treatment in conjunctival Pyogenic GranulomPyogenic granuloma.Pyogenic granulomaL98.0IRCT20160523028008N27Hamedan University of Medical Sciences46
已完成
1 期
To determine effectiveness of topical application of 0.5% Timolol Maleate in treatment of chronic heel recalcitrant fissuresIRCT20230712058759N1Pak Emirates Military Hospital150
进行中（未招募）
1 期
Study to evaluate efficacy and safety of topical administration of timolol maleate 0.5% solution in the treatment of Child Proliferative Hemangioma Early Stage SurfaceChildren Superficial HemangiomaEUCTR2013-005199-17-ESInstitut de Recerca HSCSP70